David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.55% |
| 2 | Consumer Discretionary | 8.97% |
| 3 | Financials | 8.5% |
| 4 | Healthcare | 8.44% |
| 5 | Industrials | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Under Armour Class C
UA
$2.15B
| $16.4M | 0.01% |
2,838,717
-204,154
| -7% | -$1.29M |
|
1202
ANI Pharmaceuticals
ANIP
$1.74B
| $16.4M | 0.01% |
213,433
-40,103
| -16% | -$3.13M |
|
1203
Kraft Heinz
KHC
$30B
| $16.4M | 0.01% |
727,036
-577,085
| -44% | -$13.6M |
|
1204
AMN Healthcare
AMN
$1.31B
| $16.3M | 0.01% |
891,142
-769,570
| -46% | -$14.6M |
|
1205
PUT
Morgan Stanley
MS
$340B
| $16.3M | 0.01% |
98,900
-257,600
| -72% | -$44.6M |
|
1206
CALL
British American Tobacco
BTI
$122B
| $16.3M | 0.01% |
278,200
+104,300
| +60% | +$6.17M |
|
1207
Acadia Pharmaceuticals
ACAD
$5.27B
| $16.2M | 0.01% |
729,836
-296,949
| -29% | -$7.1M |
|
1208
LCI Industries
LCII
$2.55B
| $16.2M | 0.01% |
131,933
-61,225
| -32% | -$8.37M |
|
1209
CALL
First Majestic Silver
AG
$10.5B
| $16.2M | 0.01% |
754,900
+609,100
| +418% | +$14M |
|
1210
Chemed
CHE
$7.11B
| $16.2M | 0.01% |
42,909
-16,564
| -28% | -$7.09M |
|
1211
CALL
JD.com
JD
$39.7B
| $16.1M | 0.01% |
546,100
-1,554,500
| -74% | -$43.9M |
|
1212
Orion
OEC
$337M
| $16.1M | 0.01% |
2,476,793
+110,939
| +5% | +$657K |
|
1213
PUT
Enphase Energy
ENPH
$4.94B
| $16.1M | 0.01% |
425,000
-371,600
| -47% | -$15.4M |
|
1214
CALL
Opendoor
OPEN
$3.5B
| $16M | 0.01% |
3,423,200
-6,264,300
| -65% | -$33.8M |
|
1215
CALL
Fair Isaac
FICO
$24.6B
| $16M | 0.01% |
15,000
+10,000
| +200% | +$13.7M |
|
|
GLIBK
1216
Liberty Capital Corp Series C GCI Group Common Stock
GLIBK
$1.05B
| $16M | 0.01% |
430,053
-5,137
| -1% | -$194K |
|
1217
PROG Holdings
PRG
$1.59B
| $16M | 0.01% |
557,268
-215,668
| -28% | -$6.96M |
|
1218
BioMarin Pharmaceuticals
BMRN
$12.8B
| $16M | 0.01% |
282,460
-721,569
| -72% | -$42.1M |
|
1219
CALL
Hims & Hers Health
HIMS
$7.41B
| $15.9M | 0.01% |
767,500
-2,281,000
| -75% | -$53.9M |
|
1220
CALL
Vertiv
VRT
$98.5B
| $15.9M | 0.01% |
63,500
-223,000
| -78% | -$49.5M |
|
1221
Delek US
DK
$4.14B
| $15.9M | 0.01% |
352,722
-215,725
| -38% | -$7.71M |
|
1222
OneMain Financial
OMF
$7.27B
| $15.9M | 0.01% |
296,806
+280,419
| +1,711% | +$16.6M |
|
1223
Ovintiv
OVV
$17.8B
| $15.9M | 0.01% |
267,225
-920,664
| -78% | -$44.4M |
|
1224
Organon & Co
OGN
$3.61B
| $15.8M | 0.01% |
2,644,552
-742,172
| -22% | -$5.58M |
|
1225
CALL
Celsius Holdings
CELH
$8.94B
| $15.8M | 0.01% |
446,100
-964,800
| -68% | -$45.7M |
|
Similar funds
David Shaw's Q1 2026 Portfolio in Review
As of Q1 2026, David Shaw held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
David Shaw withdrew a net $15.1B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, David Shaw opened a new position in Venture Global Inc worth $211M.
- David Shaw's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- David Shaw added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- David Shaw's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- David Shaw fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- David Shaw's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- David Shaw opened 685 new positions and closed 756 in Q1 2026.
- David Shaw's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.